EP2836508
INSULIN FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.4.2013EP published:
29.6.2016EP application number:
13714303.8
EPO information:
European Patent Register
Max expiry date:
4.4.2033
Title:
INSULIN FORMULATIONS
Timeline
Today
5.4.2013EP application
29.6.2016EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
NAVER, HelleAddress:
Bagsværd, DK
Name:
SCHLEIN, MortenAddress:
Bagsværd, DK
Name:
STEENSGAARD, Dorte BjerreAddress:
Bagsværd, DK
Name:
PETTERSON, Ingrid VivikaAddress:
Bagsværd, DK
Priority
Number:
12163730Date:
11.4.2012Country:
EP
Number:
201261624463 PDate:
16.4.2012Country:
US
Number:
13157748Date:
5.3.2013Country:
EP
Number:
201361778554 PDate:
13.3.2013Country:
US
Classification
Categories:
A61K 47/00